Clinical Trial Update: A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of Oraxol in breast cancer patients has been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Oraxol

Snippet

Sponsor: Health Hope Pharma | Conditions: Breastcancer | Phase 1 | Status: COMPLETED | Results posted: 2020-07-08